Joel Morganroth M.D.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy

Leonard N. Horowitz, Scott R. Spielman, Allan M. Greenspan, Gary S. Mintz, Joel Morganroth, Robert Brown, Patricia M. Brady, Harold R. Kay

Journal:

Journal of the American College of Cardiology

Year:

1985

Language:

english

File:

PDF, 687 KB

english, 1985

2

A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment

Joel Morganroth

Journal:

Journal of Electrocardiology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

3

Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development

Ihor Gussak, Jeffrey Litwin, Robert Kleiman, Scott Grisanti, Joel Morganroth

Journal:

Journal of Electrocardiology

Year:

2004

Language:

english

File:

PDF, 72 KB

english, 2004

4

THE ATHLETE'S HEART SYNDROME: A NEW PERSPECTIVE

Joel Morganroth, Barry J. Maron

Journal:

Annals of the New York Academy of Sciences

Year:

1977

Language:

english

File:

PDF, 528 KB

english, 1977

5

A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancers

Pamela A. Morganroth, Joel M. Gelfand, Anokhi Jambusaria, David J. Margolis, Christopher J. Miller

Journal:

Journal of the American Academy of Dermatology

Year:

2009

Language:

english

File:

PDF, 236 KB

english, 2009

6

Effects of Food on the Bioequivalence of Different Verapamil Sustained-Release Formulations

Waldman, Scott A., Morganroth, Joel

Journal:

Journal of Clinical Pharmacology

Year:

1995

Language:

english

File:

PDF, 821 KB

english, 1995

7

Comparative Left Ventricular Dimensions in Trained Athletes

MORGANROTH, JOEL

Journal:

Annals of Internal Medicine

Year:

1975

Language:

english

File:

PDF, 601 KB

english, 1975

8

Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit

Shah, Rashmi R., Morganroth, Joel

Journal:

Year:

2015

Language:

english

File:

PDF, 578 KB

english, 2015

9

Management of Visible Granulomas Following Periorbital Injection of Poly-L-Lactic Acid

Stewart, Daniel B., Morganroth, Greg S., Mooney, Maureen A., Cohen, Joel, Levin, Peter S., Gladstone, Hayes B.

Journal:

Ophthalmic Plastic & Reconstructive Surgery

Year:

2007

Language:

english

File:

PDF, 732 KB

english, 2007

10

Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty

Frank V. Brozovich, Joel Morganroth, Neil B. Gottlieb, Ronald S. Gottlieb

Journal:

Catheterization and Cardiovascular Interventions

Year:

1991

Language:

english

File:

PDF, 457 KB

english, 1991

11

Impact of prehospital cardiac algorithms on ventricular fibrillation survival rates

C. Gene Cayten, Rudolf Staroscik, Kathleen Walker, Joel Morganroth, Jacqueline Oler

Journal:

Annals of Emergency Medicine

Year:

1981

Language:

english

File:

PDF, 399 KB

english, 1981

12

The effect of telemetry on urban prehospital cardiac care

C Gene Cayten, Jacqueline Oler, Kathleen Walker, Jane Murphy, Joel Morganroth, Rudoff Staroscik

Journal:

Annals of Emergency Medicine

Year:

1985

Language:

english

File:

PDF, 611 KB

english, 1985

13

Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval

Michael S. Gillen, Barry Miller, Philip Chaikin, Joel Morganroth

Journal:

British Journal of Clinical Pharmacology

Year:

2001

Language:

english

File:

PDF, 57 KB

english, 2001

14

Early and late proarrhythmia from antiarrhythmic drug therapy

Joel Morganroth

Journal:

Cardiovascular Drugs and Therapy

Year:

1992

Language:

english

File:

PDF, 377 KB

english, 1992

15

Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias

Joel Morganroth

Journal:

Cardiovascular Drugs and Therapy

Year:

1990

Language:

english

File:

PDF, 435 KB

english, 1990

16

No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a ‘thorough QT/QTc study’ performed according to ICH guidelines

Ester Donado, Iñaki Izquierdo, Iñaki Pérez, Olga García, Rosa Ma Antonijoan, Ignaci Gich, Anna Solans, Juana Peña, Joel Morganroth, Manuel J. Barbanoj

Journal:

British Journal of Clinical Pharmacology

Year:

2010

Language:

english

File:

PDF, 862 KB

english, 2010

17

New Insights into the Drug Treatment of Ventricular Arrhythmias

Pasquale F. Nestico, Joel Morganroth

Journal:

International Journal of Dermatology

Year:

1984

Language:

english

File:

PDF, 630 KB

english, 1984

18

How to Obtain and Analyze Electrocardiograms in Clinical Trials : Focus on Issues in Measuring and Interpreting Changes in the QTc Interval Duration

Joel Morganroth M.D., Steven S. Silber M.D.

Journal:

Annals of Noninvasive Electrocardiology

Year:

1999

Language:

english

File:

PDF, 1.25 MB

english, 1999

19

Electrocardiographic Identification of Drug-Induced QT Prolongation: Assessment by Different Recording and Measurement Methods

Nenad Sarapa, Joel Morganroth, Jean-Philippe Couderc, Steven F. Francom, Borje Darpo, Joseph C. Fleishaker, Janet D. McEnroe, William T. Chen, Wojciech Zareba, Arthur J. Moss

Journal:

Annals of Noninvasive Electrocardiology

Year:

2004

Language:

english

File:

PDF, 246 KB

english, 2004

20

SV40 Virus-induced Tumour Specific Transplantation Antigen in Cultured Mouse Cells

SMITH, RICHARD W., MORGANROTH, JOEL, MORA, PETER T.

Journal:

Year:

1970

File:

PDF, 606 KB

1970

21

Cibenzoline plasma concentration and antiarrhythmic effect

Brazzell, Romulus K, Aogaichi, Keiko, Heger, James J, Somberg, John C, Carliner, Nathan H, Morganroth, Joel

Journal:

Clinical Pharmacology & Therapeutics

Year:

1984

Language:

english

File:

PDF, 598 KB

english, 1984

22

Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients

Morrison, Gail, Michelson, Eric L, Brown, Steven, Morganroth, Joel

Journal:

Kidney International

Year:

1980

File:

PDF, 812 KB

1980

23

Cellular and humoral sensitivity to gluten fractions in patients with treated nontropical sprue

Joel Morganroth, David W. Watson, Arthur B. French

Journal:

Digestive Diseases and Sciences

Year:

1972

Language:

english

File:

PDF, 503 KB

english, 1972

24

Sensitivity to atypical mycobacterial antigens in patients with Crohn's disease

Joel Morganroth, David W. Watson

Journal:

Digestive Diseases and Sciences

Year:

1970

Language:

english

File:

PDF, 282 KB

english, 1970

25

Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers

Adam del Corral, Catherine Dutreix, Alice Huntsman-Labed, Sebastien Lorenzo, Joel Morganroth, Robert Harrell, Yanfeng Wang

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2012

Language:

english

File:

PDF, 368 KB

english, 2012

26

Encainide for ventricular arrhythmias: Placebo-controlled and standard comparison trials

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1986

Language:

english

File:

PDF, 930 KB

english, 1986

27

Introduction

Donald C. Harrison, Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1986

Language:

english

File:

PDF, 751 KB

english, 1986

28

Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia—A status report, 1987

Leonard N. Horowitz, Douglas P. Zipes, J.Thomas Bigger Jr., Ronald W.F. Campbell, Joel Morganroth, Philip J. Podrid, Michael R. Rosen, Raymond L. Woosley

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 325 KB

english, 1987

29

Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone

Angelo A.V. De Paola, Leonard N. Horowitz, Scott R. Spielman, Patricia Brady, Joel Morganroth, Allan M. Greenspan, Harold R. Kay

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 586 KB

english, 1987

30

Risk factors for the development of proarrhythmic events

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 670 KB

english, 1987

31

Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 631 KB

english, 1987

32

Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 782 KB

english, 1987

33

Pharmacokinetics of moricizine HCl

Raymond L. Woosley, Joel Morganroth, Richard N. Fogoros, F.Gilbert McMahon, J.O'Neal Humphries, Dean T. Mason, Roger L. Williams

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 574 KB

english, 1987

34

Introduction

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 495 KB

english, 1987

35

Efficacy and tolerance of ethmozine® (moricizine HCl) in placebo-controlled trials

Joel Morganroth, Craig M. Pratt, Harold L. Kennedy, Steven N. Singh, Marc L. Platt, Bonnie J. Baker, Dean T. Mason

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 432 KB

english, 1987

36

Efficacy of oral and intravenous indecainide in ventricular arrhythmias

Pasquale F. Nestico, Joel Morganroth, Leonard N. Horowitz, Colleen Mulhern

Journal:

The American Journal of Cardiology

Year:

1987

Language:

english

File:

PDF, 648 KB

english, 1987

37

Antiarrhythmic effect of a 5-hydroxytryptamine M-receptor antagonist, ICS 205-930

Joel Morganroth, Colleen McGinn

Journal:

The American Journal of Cardiology

Year:

1988

Language:

english

File:

PDF, 252 KB

english, 1988

38

Evaluation of antiarrhythmic therapy using Holter monitoring

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1988

Language:

english

File:

PDF, 644 KB

english, 1988

39

Antiarrhythmic drug therapy 1988: For whom, how and where?

Joel Morganroth, Leonard N. Horowitz

Journal:

The American Journal of Cardiology

Year:

1988

Language:

english

File:

PDF, 645 KB

english, 1988

40

Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine®)

Joel Morganroth, Craig M. Pratt

Journal:

The American Journal of Cardiology

Year:

1989

Language:

english

File:

PDF, 605 KB

english, 1989

41

Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy

William B. White, Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1989

Language:

english

File:

PDF, 609 KB

english, 1989

42

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available

Joel Morganroth, J.Thomas Bigger, Jeffrey L. Anderson

Journal:

The American Journal of Cardiology

Year:

1990

Language:

english

File:

PDF, 821 KB

english, 1990

43

Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial

Joel Morganroth, J. Thomas Bigger Jr.

Journal:

The American Journal of Cardiology

Year:

1990

Language:

english

File:

PDF, 935 KB

english, 1990

44

Placement of moricizine in the selection of antiarrhythmic drug therapy

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1990

Language:

english

File:

PDF, 380 KB

english, 1990

45

Dose effect of moricizine on suppression of ventricular arrhythmias

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1990

Language:

english

File:

PDF, 528 KB

english, 1990

46

Overview: Moricizine—Can it meet the challenge?

Joel Morganroth, J.Thomas Bigger Jr.

Journal:

The American Journal of Cardiology

Year:

1990

Language:

english

File:

PDF, 955 KB

english, 1990

47

Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia

Joel Morganroth, Frank V. Brozovich, John T. McDonald, Robert A. Jacobs

Journal:

The American Journal of Cardiology

Year:

1991

Language:

english

File:

PDF, 434 KB

english, 1991

48

Reply

J.Thomas Bigger Jr., Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1991

Language:

english

File:

PDF, 335 KB

english, 1991

49

Sudden death during ambulatory electrocardiographic monitoring

Carl J. Pepine, Joel Morganroth, John T. McDonald, Sidney O. Gottlieb

Journal:

The American Journal of Cardiology

Year:

1991

Language:

english

File:

PDF, 1.60 MB

english, 1991

50

Relations of QTc prolongation on the electrocardiogram to torsades de pointes: Definitions and mechanisms

Joel Morganroth

Journal:

The American Journal of Cardiology

Year:

1993

Language:

english

File:

PDF, 409 KB

english, 1993

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски